Boothbay Fund Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1473 |
|
|
2024
Q1 | – | Sell |
-125
| Closed | -$29.4K | – | 1519 |
|
|
2023
Q4 | $29.4K | Buy |
+125
| New | +$29.4K | ﹤0.01% | 1408 |
|
|
2020
Q2 | – | Sell |
-134
| Closed | -$31K | – | 893 |
|
|
2020
Q1 | $31K | Buy |
+134
| New | +$31K | ﹤0.01% | 705 |
|
|
2019
Q4 | – | Sell |
-300
| Closed | -$129K | – | 795 |
|
|
2019
Q3 | $129K | Buy |
+300
| New | +$129K | 0.01% | 592 |
|